Class IIOngoing

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride recall

FDA recall D-0593-2026 · initiated May 18, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Subpotent Drug

Details

Product: Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Recalling company: IntegraDose Compounding Services LLC
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: U.S.A. Nationwide
Initiated: May 18, 2026
FDA report date: Jun 24, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0593-2026 ↗

← All drug recalls